|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetic Nephropathy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetic Nephropathies | |||||
| Kidney Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Diabetes Complications | |||||
| Diabetes Mellitus | |||||
| Endocrine System Diseases | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| celecoxib | |||||
| 5 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||